Authors
Yizhuo Wang, Peng Lou, Xiyue Zhou, Zehuan Lin, Shuyun Liu, Lan Li, Younan Chen, Dan Du, Hao Yang, Yanrong Lu, Meihua Wan, Jingping Liu
Published in
Journal of extracellular vesicles. Volume 15. Issue 11.
Abstract
Uncontrolled inflammation has been recognized as a vital driver of the pathology of diverse forms of tissue injury, but current anti-inflammatory drugs have unsatisfactory efficacy and safety issues. Thus, it is important to explore its underlying mechanism and develop more specific and safe therapies. Here, inspired by the intrinsic immune modulatory role of efferocytosis, we report that bioengineered efferocytic cell-derive nanovesicles can spatiotemporally regulate neutrophil-macrophage (Neu-Mac) crosstalk to promote inflammation resolution and tissue repair. We revealed that dysregulated Neu-Mac interactions drive inflammation in both acute and chronic tissue injury states. As a conserved innate immune response, the efferocytosis process can induce a robust immunoregulatory phenotype in Mac, and efferocytic Mac-derived artificial nanovesicles (ACDVEffero) can suppress hyperactivated Neus and promote their apoptosis for the subsequent MacEffero. Engineering ACDVEffero with probiotic-derived membrane contents (BNVEffero) can further increase its active Neu-targeting capacity, and these BNVEffero can hijack apoptotic Neus to transfer therapeutic payloads into Macs to increase efferocytosis, thereby driving a positive loop for promoting inflammation resolution and tissue repair. This study highlights that bioinspired nanotherapeutics can tightly and spatiotemporally control the crosstalk between different immune cell types, which provides a promising therapeutic avenue for treating diverse inflammatory disorders.
PMID:
43035380
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 15
- Comments 0